Nectar Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

41.80

-0.86 (-2.02%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

41.80

-0.86 (-2.02%)
16:02 Dec 20

Quality

84/100
High Financial Strength

Valuation

68/100
Affordable Valuation

Technical

66/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	1543.3	1668.83	1523.67	1684.09	1680.94
Operating Expenses +	1434.25	1510.29	1470.66	1532.53	1507.11
Raw Material	1052.82	1207.32	1200.84	1242.45	1253.51
Increase Decrease in Cost	104.29	15.81	-41.55	-40.21	-84.83
Other Manufacturing Expense	128.62	146.37	172.14	184.64	0
Employee Cost	73.37	74.55	77.78	84.67	93.73
Miscellaneous Expenses	123.99	67.12	61.45	60.98	244.7
Operating Profit	109.05	158.54	53.01	151.56	173.83
Other Income	3.79	11.32	43.18	14.58	3.19
Depreciation	60.25	56.97	59.12	60.72	61.08
Interest	112.04	78.81	79.49	87.14	88.79
Profit before tax and exceptio..	-59.45	34.08	-42.42	18.27	27.15
Exceptional Items	-25.32	0	0	0	0
PBT	-84.77	34.08	-42.42	18.27	27.15
Provision for Taxation	-11.5	9.03	-18.24	13.27	16.43
Net Profit	-73.26	25.05	-24.18	5	10.73
NET Profit after MI	-73.26	25.05	-24.18	5	10.73
EPS	-3.27	1.12	-1.08	0.22	0.48
Operating Profit Margin (%)	7.07	9.5	3.48	9	10.34
Net Profit Margin (%)	-4.75	1.5	-1.59	0.3	0.64

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	55.80	55.80	55.80	55.80	55.80
FII	3.20	16.60	17.00	16.10	16.00
MF	0.00	0.00	0.00	0.00	0.00
Public	40.90	27.60	27.20	28.00	28.20
Others	0.00	0.00	0.00	0.10	0.00
Others	0.10	0.00	0.00	0.00	0.00